# A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors

> **NCT04476641** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 686 (estimated)

## Conditions studied

- Liver Cancer
- Kidney Cancer
- Nasopharyngeal Cancer
- Lung Cancer
- Colorectal Cancer
- Breast Cancer

## Interventions

- **OTHER:** CELL

## Key facts

- **NCT ID:** NCT04476641
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 686 (ESTIMATED)
- **Last updated:** 2020-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476641, "A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04476641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*